Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Breast Cancer Res Treat. 2017 Sep 16;167(1):107–116. doi: 10.1007/s10549-017-4503-2

Table 1. Univariate analysis of association of CMI levels with pCR.

CMI* Tissue Serum
n OR (95% CI) P-value n OR (95% CI) P-value
Baseline 58 0.73 (0.49, 1.09) 0.129 59 1.17 (0.82, 1.67) 0.400
D15 50 0.60 (0.37, 0.97) 0.037 61 0.9 (0.57, 1.42) 0.652
Change from baseline 48 0.52 (0.26, 1.05) 0.069 58 0.83 (0.57, 1.21) 0.324
*

Natural log transformed

Change from baseline, change of CMI defined as log (D15 CMI+1/Baseline CMI+1); n, number of available samples; CI, confidence interval; CMI, cumulative methylation index; D15, 15 days after the first treatment; OR, odds ratio